Back to catalogue
№ 302 42 filings · 2021-09-24 → 2026-08-28

MITIE GROUP PLC

MTO
Industrial Goods and Services Share price 210p Market cap £2.7bn Overall fit 240 /1000

Despite high conviction in the deal-arb fair value, Mitie is a poor fit for the investor profile: ~6% bounded upside with deal-break tail risk, minimal direct AI-receiver exposure (spends on AI internally rather than selling into the buildout), low operating leverage in a people-cost-intensive FM business, and no multi-year compounding optionality as the company is about to be taken private.

Fair value range 215p–221p Mid case · £2.8bn
Absolute upside +6.4% vs current market cap
Conviction 5/5 confidence in fair call
Supports the call
  • Recommended cash scheme at 221.6p with unanimous board recommendation and published scheme document (13 Aug 2026)
  • Fully committed debt financing by OCS/CD&R with amendment letters executed 28 Aug 2026
  • Oasis Management 9.9% TRS commitment plus director irrevocable undertakings
Limits the call
  • CMA, EU Merger and UK NSIA clearances not yet obtained — Material Regulatory Conditions could lapse the scheme
  • If deal breaks, standalone fair value would re-rate back toward 150–180p (pre-bid trading range)
Methodology

Deal-arbitrage vs. recommended cash offer at 221.6p; completion expected Q1 2027

In one line · bull case

Recommended cash scheme at 221.6p offers a defined ~6% deal-arb return by Q1 2027 completion from a fundamentally well-run UK FM leader with strong operating momentum.

In one line · biggest risk

CMA, EU and UK National Security Act clearances could force material remedies or scheme lapse, triggering a sharp re-rating back toward the pre-bid 150p area.

Drivers
AI beneficiary 25 /100
Mitie spends on AI internally (PRIO/agentic workflow program) rather than selling into the AI buildout; limited indirect exposure via data-centre fit-out and power/grid Projects work.
Operating leverage 30 /100
People-cost-intensive FM model with cost-plus/indexed contracts; incremental margin on organic growth modest, no network effects or spare capacity to monetise.
Earnings vs expectations 80 /100
Consistent record of in-year guidance upgrades and FY delivery above initial outlook across FY23-FY26.
Growth momentum 70 /100
Record order book £16.3bn and pipeline £32.5bn, double-digit revenue growth sustained; Marlowe cross-sell adds compliance growth lever.
Moat 45 /100
Scale advantages in UK FM, technology investment (Mozaic360, Marlowe) and sticky long-tenure contracts, but industry remains contestable with low switching costs on re-tender.
Earnings quality 72 /100
Clean cash conversion (£162m FCF on £264m operating profit FY26); recurring Other items primarily acquisition-related amortisation and TOM/PRIO restructuring costs.
Management quality 72 /100
Phil Bentley (CEO ~10 years) has delivered strong operating record; Marlowe acquisition executed well; capital return discipline evident via buybacks and progressive dividend.
Cyclicality 35 /100
Mostly defensive public-sector and essential private-sector FM contracts; some cyclicality in Projects/Transformation revenue.
Leverage 35 /100
Net debt £450m at FY26, leverage 1.2x EBITDA, within 0.75-1.5x target range; BBB investment grade from DBRS.

MITIE Group plc (MTO) — Investment Research Note

Executive summary

Mitie is the UK's largest facilities management (FM) group — ~84,000 employees delivering cleaning, security, engineering maintenance and increasingly higher-margin "transformation" projects (building infrastructure, decarbonisation, fire & security, data-centre fit-out) and compliance services (post-Marlowe acquisition) to ~3,000 blue-chip public and private sector customers. Over the FY22–FY26 period revenue grew from £4.0bn to £5.6bn and operating profit margin before other items expanded from 4.2% to 4.7%, with strong free cash flow generation (£162m FY26) and a growing order book (£16.3bn) and pipeline (£32.5bn at Q1 FY27). The single most important point for valuation today is that Mitie is subject to a recommended cash acquisition by OCS Group at 218.5p + 3.1p final dividend = 221.6p per share, announced 21 July 2026 and expected to complete in Q1 2027 2026-07-21 Rule 2.7 announcement — the share price is effectively anchored to deal terms pending regulatory clearances.

Fair value estimate

  • Fair value range: 215p – 221p per share (implied mcap ~£2,800m – £2,884m fully-diluted, or ~£2,795m – £2,879m on the 1,301m basic shares in issue).
  • Methodology: Deal arbitrage — recommended cash offer at 221.6p (incl. final dividend already approved at the 21 July AGM). Scheme Document published 13 August 2026 2026-08-28 offer update; expected completion Q1 2027. Low end of range reflects a 5–7% probability-weighted discount for Material Regulatory Conditions (CMA, EU Merger Regulation, UK National Security Act clearances) remaining outstanding, with debt financing already arranged (amendment letters dated 28 August 2026).
  • Comparison to current mcap of £2,663.4m: Fair value mid of ~£2,840m implies ~6.6% absolute upside from current price (210.20p vs. 218.5p cash + 3.1p dividend). The spread reflects regulatory/completion risk.
  • Standalone fair value sanity check: Pre-bid 20 July 2026 close was 151p; the all-time high before bid was 185.7p (14 April 2026). On FY26 EPS before other items of 13.6p, standalone trailing P/E at 150p was ~11x — reasonable for a mid-cap UK industrials services business with mid-single-digit organic growth and ~5% operating margins. Standalone fair value would plausibly be 160–180p, i.e. the OCS premium (44.7%) captures roughly 2–3 years of forward growth.

Sector context

  • Sector classification confirmed: Industrial Goods and Services (ICB Super-Sector) — Mitie is the largest UK pure-play facilities management business. Classification is appropriate.
  • Quality/growth/leverage profile: In line with sector peers. Revenue growth has been well above market (~10% vs. UK FM ~2–3%) via M&A and projects upsell, but structural margins (~4.7%) and leverage (1.2x) are typical for the sub-sector.
  • Listed peers: Compass Group plc (CPG, contract catering), Serco Group plc (SRP, government outsourcing), Rentokil Initial plc (RTO, pest control/hygiene). All share mid-single-digit margin profiles and high people-cost intensity.

Investment thesis (3 bullets)

  1. Deal-arb return of ~6% in ~6 months: The OCS offer at 221.6p is unanimously recommended by Mitie directors, financing is fully committed, and Oasis Management (9.9% via TRS) has given a commitment to vote in favour 2026-07-21 Rule 2.7 announcement; 2026-08-28 offer update. This represents a defined-timeline, defined-return opportunity if regulatory conditions clear.
  2. Strategic foundation underpins deal rationale: Even on a standalone basis, Mitie has delivered three consecutive years of double-digit revenue and operating-profit growth, with Marlowe integration (acquired £350m, Aug 2025) adding fast-growing "Facilities Compliance" scale and £7m of H1 cost synergies already achieved 2026-06-04 FY26 results; 2026-07-21 Q1 FY27 update. Order book of £16.3bn and pipeline of £32.5bn provide multi-year revenue visibility.
  3. Agentic AI program ("PRIO") delivering internal productivity gains: Mitie launched an enterprise-wide "Process Reimagination and Optimisation" programme in April 2026 to apply agentic AI across engineering field-force, hire-to-retire, cleaning and security workflows, with FY27 cost of £20–25m but medium-term savings expected to "significantly exceed" that outlay 2026-07-21 Q1 FY27 update. This supports underlying margin trajectory if the deal were to lapse.

Key risks (3 bullets)

  1. Regulatory block / remedy risk: The CMA, EU Merger Regulation and UK National Security Act (NSIA) clearances are "Material Regulatory Conditions" that could lapse the scheme. OCS has rights to invoke to abandon if the CMA refers to Phase 2 (unless both parties agree) or if remedies are "adverse to a material extent" — this is the single most meaningful deal-break risk 2026-07-21 Rule 2.7 Appendix I.
  2. Standalone valuation gap if deal breaks: If the deal lapses, shares would likely re-rate back towards the pre-bid 150p area (a ~29% drawdown from today's 210p) — the current price embeds high deal-completion probability.
  3. High fixed government/defence contract exposure to policy or re-tender losses: Historical track record shows that Mitie has lost two sizeable public-sector contracts in FY25 (reducing renewal rate to 59% that year) 2025-06-05 FY25 results, and large pipeline is dependent on long UK public-sector procurement cycles that are sensitive to political shifts.

Operating leverage

Mitie has moderate-to-low operating leverage. FY26 EBITDA was £360m on revenue of £5,619m (6.4% EBITDA margin); operating profit margin before other items was 4.7%. Over FY22–FY26, 2.6ppts of revenue growth from inflationary pass-through has roughly matched gross cost inflation, meaning incremental margin on organic growth has been modest (~5–10% contribution margin on incremental revenue above pricing). Labour is the dominant variable cost (£2.1bn of employment costs on £5.1bn revenue in FY25); contracts are predominantly cost-plus or indexed, limiting operating leverage. The exceptions are the Projects/Marlowe compliance businesses (c.£1.4bn Facilities Transformation + £0.4bn Compliance revenue in FY26 at mid-to-high single-digit margins) and the PRIO AI programme, which has the potential to reduce fixed back-office costs. A 10–20% revenue beat above expectations would plausibly add ~15–25% to operating profit, not multiples — this is not a long-tail operating-leverage story 2026-06-04 FY26 results Finance review.

Value-trap signals

None identified in the near term — but note that absent the OCS bid, the shares would be a "fairly priced UK industrials services stock" rather than a value trap. The one historically challenged PFI contract in Communities ran at £8.4m loss in FY23 narrowing to small profit in FY26; otherwise, financials are clean, cash-converting, with investment-grade BBB credit rating 2025-07-21 Q1 FY26 update.

Earnings vs. expectations

Across the five-year period Mitie has consistently met or beat guidance. Representative examples: FY23 operating profit guidance of "at least £145m" (Jan 2023 upgrade) delivered at £162m; FY24 guidance of "at least £190m" (Nov 2023) delivered at £210m; FY25 guidance raised multiple times, final delivery of £234m vs. initial outlook of £200m+; FY26 full-year delivered £264m vs. guidance "at least £260m". FY25-FY27 Strategic Plan targets (high single-digit growth, >5% operating margin by FY27, £150m annual free cash flow) are tracking ahead of schedule. Pattern: consistent and material upward re-rating of guidance across most reporting cycles — a strong operational delivery track record under CEO Phil Bentley.

Conviction

Conviction: 5 (very high). The fair-value call is anchored to a public, binding recommended-cash scheme of arrangement with 221.6p explicit cash consideration, unanimous board recommendation, Oasis TRS commitment, fully-committed debt financing, and defined timetable to Q1 2027 completion. Methodology is unambiguous (deal arb).

  • Anchoring factors: (i) scheme document already published 13 Aug 2026; (ii) final dividend already approved at AGM 21 July 2026; (iii) directors' irrevocable undertakings and Oasis commitment.
  • Limiting factors: Material Regulatory Conditions (CMA/EU/NSIA) are not yet cleared, which creates a small but real deal-break tail risk.

Driver scoring and overall score rationale

For the investor profile described (AI receivers, valuation discipline, operating leverage), Mitie is a poor fit despite the deal-arb attractiveness. There is minimal upside beyond deal completion, zero long-tail AI optionality, modest operating leverage, and no multi-year compounding opportunity. The ~6% deal-arb spread is a defined, bounded return — not a strategic AI-receiver position. Overall score reflects this: it is a defensive deal-arb trade, not a strategic holding.

Filings consulted · 36

Every document the LLM read for this note. Click any row to open the source.

  1. 2026-08-28Offer Update2026-08-28_9746440_offer-update.md0.80
  2. 2026-07-21Result OF Agm2026-07-21_9680223_result-of-agm.md0.30
  3. 2026-07-21Recommended Cash Acquisition OF Mitie Group Plc2026-07-21_9678464_recommended-cash-acquisition-of-mitie-group-plc.md0.75
  4. 2026-07-21Q1 Fy27 Trading Update2026-07-21_9678461_q1-fy27-trading-update.md0.85
  5. 2026-06-04Full Year Results For The Year Ended 31 March 20262026-06-04_9600664_full-year-results-for-the-year-ended-31-march-2026.md1.00
  6. 2026-04-16Fy26 Trading Update2026-04-16_9522436_fy26-trading-update.md0.85
  7. 2026-01-27Q3 Fy26 Trading Update2026-01-27_9388014_q3-fy26-trading-update.md0.72
  8. 2025-10-14H1 Fy26 Trading Update2025-10-14_9168719_h1-fy26-trading-update.md0.72
  9. 2025-08-04Mitie Completes The Acquisition OF Marlowe Plc2025-08-04_9025433_mitie-completes-the-acquisition-of-marlowe-plc.md0.49
  10. 2025-07-22Result OF Agm2025-07-22_8992541_result-of-agm.md0.20
  11. 2025-07-22Q1 Fy26 Trading Update2025-07-22_8990192_q1-fy26-trading-update.md0.55
  12. 2025-06-05Full Year Results For The Year Ended 31 March 20252025-06-05_8913537_full-year-results-for-the-year-ended-31-march-2025.md0.65
  13. 2025-04-16Q4 Trading Update2025-04-16_8833218_q4-trading-update.md0.55
  14. 2025-01-23Q3 Trading Update2025-01-23_8701768_q3-trading-update.md0.55
  15. 2024-10-15H1 Fy25 Trading Update2024-10-15_8485850_h1-fy25-trading-update.md0.55
  16. 2024-07-23Result OF Agm2024-07-23_8326660_result-of-agm.md0.14
  17. 2024-07-23Q1 Fy25 Trading Update2024-07-23_8324473_q1-fy25-trading-update.md0.38
  18. 2024-06-06Full Year Results For The Year Ended 31 March 20242024-06-06_8244989_full-year-results-for-the-year-ended-31-march-2024.md0.45
  19. 2024-04-24Results OF Secondary Placing IN Mitie Group Plc2024-04-24_8153224_results-of-secondary-placing-in-mitie-group-plc.md0.32
  20. 2024-04-23Proposed Secondary Placing IN Mitie Group Plc2024-04-23_8152882_proposed-secondary-placing-in-mitie-group-plc.md0.32
  21. 2024-04-15Fy24 Full Year Trading Update2024-04-15_8136346_fy24-full-year-trading-update.md0.38
  22. 2024-01-25Q3 Trading Update2024-01-25_8005394_q3-trading-update.md0.38
  23. 2023-11-23Interim Results2023-11-23_7898327_interim-results.md0.41
  24. 2023-10-11H1 Fy24 Pre Close Trading Update2023-10-11_7808779_h1-fy24-pre-close-trading-update.md0.21
  25. 2023-09-14Notice OF Capital Markets Day2023-09-14_7756080_notice-of-capital-markets-day.md0.24
  26. 2023-07-25Result OF Agm2023-07-25_7654296_result-of-agm.md0.07
  27. 2023-07-25Q1 Trading Update2023-07-25_7652307_q1-trading-update.md0.21
  28. 2023-06-08Full Year Results For The Year Ended 31 March 20232023-06-08_7565003_full-year-results-for-the-year-ended-31-march-2023.md0.25
  29. 2023-05-02Acquisition OF R H Irving Industrials Ltd2023-05-02_7507468_acquisition-of-r-h-irving-industrials-ltd.md0.19
  30. 2023-04-18Fy23 Trading Update2023-04-18_7463102_fy23-trading-update.md0.21
  31. 2023-01-26Q3 Trading Update2023-01-26_7229214_q3-trading-update.md0.21
  32. 2022-07-26Result OF Agm2022-07-26_7179416_result-of-agm.md0.07
  33. 2022-07-26Q1 Trading Update2022-07-26_7136132_q1-trading-update.md0.21
  34. 2022-06-09Full Year Results For The Year Ended 31 March 20222022-06-09_6871707_full-year-results-for-the-year-ended-31-march-2022.md0.25
  35. 2022-01-27Q3 Trading Update2022-01-27_6996519_q3-trading-update.md0.21
  36. 2021-09-24Trading Update2021-09-24_6559313_trading-update.md0.09

This research note was authored by a large language model after reading 42 regulatory filings published between 2021-09-24 and 2026-08-28. Each citation refers to a specific RNS announcement in the underlying data set. The note is an opinion, not advice. Do your own work before risking capital.